|
|
 |
Gliomas
There
are two broad categories of brain tumors: tumors which occur
elsewhere in the body and metastasize to the brain, and tumors
which arise from the tissues of the brain itself and its
surrounding membranes. Cancer of the lung and breast, as well
as melanoma frequently metastasize to the brain. Their
treatment and prognosis is different from primary brain
tumors.
All
of the tissues of the brain may give rise to benign and
malignant tumors. By far the most common cell of origin is the
glial cell, producing gliomas. Gliomas are further subdivided,
into more specific cell types: oligodendroglioma, pilocytic
astrocytoma, astrocytoma, and ependymoma. These tumors range
from an extremely a benign tumor, which may not progress,
pilocytic astrocytomas, to the most malignant of brain tumors,
the glioblastoma multiforme.
| WHO
Classification of Gliomas |
Grade
1 pilocystic astrocytoma
|
Benign
astrocytomas |
Grade
2 diffuse astrocytoma
|
| Grade
3 anaplastic astrocytoma |
Malignant
astrocytomas |

Grade
4 glioblastoma multiforme |
The
glial cells are the supporting cells of the brain, forming the
structure holding and nourishing the nerve cells and their
processes. They are the most common cells of the brain. Glial
tumors may arise anywhere within the central nervous system
including the optic nerves and spinal cord. Hence the symptoms
caused by gliomas include dysfunction of any part of the CNS.
Generally speaking, gliomas present with symptoms of focal
dysfunction of the brain: weakness, numbness, visual loss.
Tumors which begin in "silent areas" of the brain can
become very large before the patient develops symptoms of mass-effect
from increased pressure within the head: headache and lethargy.
Gliomas can irritated the brain and produce seizures.
Rarely gliomas may spontaneously hemorrhage, presenting as a stroke.
The
diagnosis of gliomas is usually straight forward. The tumors are
imaged by MRI scanning using intravenous contrast dye. MR
spectroscopy (MRS) is a technique which may add to diagnosis by
providing clues about the chemical nature of the tumor. The
imaging characteristics usually do not confirm a diagnosis with
certainty ... for example the image characteristics of a glioblastoma
is
similar to that of a brain abscess. The gold standard for
diagnosis is a brain biopsy. The biopsy may be excisional, by
open operation on the brain, or stereotactic, using a small,
guided probe to sample a small amount of tissue. The microscopic
appearance of biopsied tissue, aided by special tissue stains usually produces a definitive
diagnosis. Accurate diagnosis allows accurate advise for
treatment options and an estimate of overall prognosis.
The
treatment of gliomas is evolving. Low grade tumors which are not
growing and causing progressive symptoms need no treatment.
Malignant gliomas cannot be totally removed by surgery and
require additional treatment. The most effective treatment is
radiation therapy which can slow-down or stop tumor progression
for a period of time. Recent advances in chemotherapy for
malignant gliomas with temazolamide have extended survival.
Other, established chemotherapeutic protocols and experimental
protocols may be useful. Local irradiation with radioactive
Iodine-125 (Gliasite Balloon) at the initial time of surgery or
with tumor recurrence may be fruitful. Radiosurgical boost of
tumor re-growth and re-operation are additional tactics used to
treat tumor progression after initial radiation therapy.
|